IFNA2 and leukemia: For example, a preclinical study [209] showed that intratumoral injection of an adenoviral vector encoding IFNα2b (IACB) suppressed the growth of xenografts, including glioblastoma (U87MG) and leukemia (K562) models; significant growth inhibition was also observed with systemic administration.